PET/CT: Role in Detecting Unknown Primary Head and Neck Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00656760|
Recruitment Status : Completed
First Posted : April 11, 2008
Last Update Posted : May 18, 2016
|Condition or disease||Intervention/treatment||Phase|
|Head and Neck Cancer||Other: PET/CT||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Single (Care Provider)|
|Official Title:||The Clinical Utility of PET-CT in the Management of Squamous Cell Carcinoma of Neck Nodes With an Unknown Primary Malignancy.|
|Study Start Date :||July 2007|
|Actual Primary Completion Date :||March 2011|
|Actual Study Completion Date :||March 2011|
All patients have PET/CT and biopsies with the surgeon blinded to the result of PET/CT. Additional biopsies are performed (or not) after the surgeon has the PET/CT results revealed.
PET/CT is being performed on all patients in the study.
- proportion of patients where PET/CT resulted in a change in diagnosis [ Time Frame: 2 weeks after surgery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00656760
|Tom Baker Cancer Centre|
|Calgary, Alberta, Canada|